Market sizing, competitor and price benchmarking, registration strategy, distributor and partner selection, launch plan and KOL engagement — from a team that buys these products for hospitals.
Most launches fail on three things: a price that was set from the home market, a distributor chosen for availability rather than reach, and a registration timeline that slipped past the tender season. The people who see this most clearly are the hospital buyers — and that is where Consulting Wallah comes from.
We size the market from real hospital demand, benchmark the price against what buyers actually pay today, map the registration route, select and negotiate with distributors, and build the launch plan with the formulary, tender and KOL calendar in view.
Market sizing from hospital demand, competitor landscape, price and reimbursement benchmarking.
Registration strategy and dossier coordination, distributor and partner selection, commercial terms and channel design.
Launch plan, KOL engagement, tender calendar, formulary listing, first-year sales targets and tracking.
Product, markets, timeline.
Size, price, competitors, route.
Dossiers, distributors, terms.
KOLs, tenders, formularies, tracking.
Pharmaceuticals, medical devices, consumables, diagnostics and health-tech — into the UAE as the primary market, and into India; other GCC markets on request.
No. We are independent advisors; we select and negotiate with distributors on your behalf and can present your products to buyers through the Consulting Wallah Network.
Against what hospital buyers in the market pay today, drawn from our procurement practice and the Network, not from list prices.
Yes — first-year sales tracking, tender support and a retainer for commercial and regulatory follow-up.